Rockville biotech RegenxBio launches clinical trial in muscular dystrophy

It's one of a series of treatments RegenxBio is developing as it aims to bring multiple products to market by 2025.

Source: bizjournals.com Health Care:Physician Practices headlines - January 24, 2023 Category: American Health Authors: Sara Gilgore Source Type: news